Pfizer (PFE -1.31%) made a deal with the White House to avoid paying tariffs on imported products.
*Stock prices used were the afternoon prices of Oct. 3, 2025. The video was published on Oct. 5, 2025.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Great News for Pfizer Stock Investors
By Parkev Tatevosian, CFA
–
Oct 6, 2025 at 7:15AM
NYSE: PFE
Pfizer
Market Cap
$156B
Today's Change
(-1.31%) -$0.36
Current Price
$27.01
Price as of October 6, 2025, 11:54 a.m. ET
Pharma stocks have been under pressure from the administration in 2025.
About the Author
A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history. You'll often find him writing about stocks in the consumer goods and technology sectors.
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Pfizer. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
Stocks Mentioned
Pfizer
PFE
$27.01
(-1.31%)
$0.36
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
3 Reasons to Buy Pfizer Stock Now
3 Dirt Cheap Stocks to Buy in a Market Priced for Perfection
Can Pfizer's Stock Break This Disappointing Streak?
Want $7,800 in Annual Passive Income? Invest $100,000 in These 3 Ultra-High-Yield Dividend Stocks.
These 3 Stocks Pay More Than 6%. Are Their Dividend Yields Too Good to Be True?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.